{
    "2019-12-20": [
        [
            {
                "time": "2020-01-03",
                "original_text": "Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Upbeat",
                        "2020 Outlook",
                        "FDA",
                        "Nod",
                        "PFE",
                        "MRK",
                        "Drugs"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-03",
                "original_text": "Novartis wins Medicaid approval for new sickle cell drug in key U.S. states",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Medicaid",
                        "approval",
                        "sickle cell",
                        "drug",
                        "U.S.",
                        "states"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}